Walgreens Boots Alliance, kaleo expand collaboration to include AUVI-q EAI
Walgreens and kaleo, a privately-held pharmaceutical company, announced AUVI-q auto-injector is available at Walgreens locations nationwide. AUVI-q is the first and only epinephrine auto-injector, or EAI, approved by the FDA for infants and toddlers weighing 16.5-33 pounds. Through this collaboration, Walgreens is the first national retail pharmacy to offer the entire AUVI-Q auto-injector product line, which also includes AUVI-Q 0.3 mg and 0.15 mg doses. As supply issues related to epinephrine auto-injector products by other manufacturers continue, the collaboration aims to broaden access to an available treatment option for patients with life-threatening allergies, especially as families prepare for back-to-school season. AUVI-Q is a prescription medicine approved by the FDA to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions.